Stockreport

Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit

Candel Therapeutics, Inc.  (CADL) 
PDF NEEDHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused [Read more]